Zobrazeno 1 - 10
of 95
pro vyhledávání: '"M. Douglas Ris"'
Autor:
Emily A. H. Warren, Kimberly P. Raghubar, Paul T. Cirino, Amanda E. Child, Philip J. Lupo, David R. Grosshans, Arnold C. Paulino, M. Fatih Okcu, Charles G. Minard, M. Douglas Ris, Anita Mahajan, Andres Viana, Murali Chintagumpala, Lisa S. Kahalley
Publikováno v:
Pediatr Blood Cancer
BACKGROUND: Pediatric brain tumor survivors are at risk for poor social outcomes. It remains unknown whether cognitive sparing with proton radiotherapy (PRT) supports better social outcomes relative to photon radiotherapy (XRT). We hypothesized that
Autor:
Heather H. Stancel, Andrew M. Heitzer, William E. Whitehead, Kimberly P. Raghubar, M. Douglas Ris, Murali Chintagumpala, M. Fatih Okcu, Lisa S. Kahalley, Marsha Gragert, Judy J Xue, Charles G. Minard, Jessica Orobio
Publikováno v:
J Neurosurg Pediatr
OBJECTIVEHigh survival rates have led to an increased emphasis on the functional outcomes of children diagnosed with low-grade glioma. Most outcomes research has focused on risks associated with radiotherapy, but less is known about neuropsychologica
Autor:
Heather M. Conklin, William E. Whitehead, Rachel K. Peterson, Normand Laperriere, Laura Janzen, David R. Grosshans, M. Fatih Okcu, Arnold C. Paulino, Vijay Ramaswamy, M. Douglas Ris, Eric Bouffet, Anita Mahajan, Murali Chintagumpala, Robert C. Dauser, Donald J. Mabbott, Lisa S. Kahalley, David C. Hodgson, Michael D. Taylor, Derek S. Tsang
Publikováno v:
Strahlentherapie Und Onkologie
PURPOSE Proton radiotherapy (PRT) may lessen the neuropsychological risk traditionally associated with cranial radiotherapy for the treatment of pediatric brain tumors by reducing the dose to normal tissue compared with that of photon radiotherapy (X
Autor:
Murali Chintagumpala, Alexandra M. Villagran, Austin L. Brown, Arnold C. Paulino, Andrew M. Heitzer, Lisa S. Kahalley, M. Fatih Okcu, Jenny H. Hanning, Kimberly P. Raghubar, M. Douglas Ris, Miranda L. Camet
Publikováno v:
J Neurooncol
PURPOSE: Survivors of pediatric embryonal brain tumors (BT) are at high risk for sensorineural hearing loss (SNHL) associated with neurocognitive decline. However, previous studies have not assessed the relationship between SNHL and adaptive function
Autor:
Arnold C. Paulino, Kimberly P. Raghubar, M. Douglas Ris, Charles G. Minard, M. Fatih Okcu, Mark A. McCurdy, Lisa S. Kahalley, Claire Stafford, Jocelyn Gomez, Murali Chintagumpala, Marsha Gragert, Andrew M. Heitzer, Emily H Warren, David R. Grosshans
Publikováno v:
Pediatr Blood Cancer
The relationship between age and neurocognitive functioning following proton beam radiotherapy (PRT) in low- and intermediate-grade gliomas (LIGG) has yet to be examined. Eighteen LIGG patients treated with PRT were prospectively enrolled and receive
Autor:
Charles G. Minard, Jessica Orobio, Paul T. Cirino, Lisa S. Kahalley, Johanna Bick, M. Douglas Ris, Anita Mahajan, Murali Chintagumpala, Arnold C. Paulino, Andres G. Viana, Emily A Warren, Amanda E. Child, M. Fatih Okcu, David R. Grosshans, Steven Paul Woods
Publikováno v:
Pediatr Blood Cancer
BACKGROUND Proton radiotherapy (PRT) may be associated with less neurocognitive risk than photon RT (XRT) for pediatric brain tumor survivors. We compared neurocognitive and academic outcomes in long-term survivors treated with XRT versus PRT. METHOD
Autor:
Chongzhi Di, Jennie G. Noll, M. Douglas Ris, Leslie L. Robison, Wendy Levy, Gregory T. Armstrong, Pamela Goodman, Wendy M. Leisenring
Publikováno v:
Cancer
BACKGROUND Current estimates suggest that 75% of children diagnosed with a central nervous system (CNS) tumor will become 5-year survivors. However, survivors of childhood CNS tumors are at increased risk for long-term morbidity. METHODS To determine
Autor:
E. Mark Mahone, Keith Owen Yeates, Kimberly P. Raghubar, Jennifer S. Haut, M. Douglas Ris, Thomas A. Duda
Publikováno v:
Child Neuropsychol
Children treated for brain tumor show evidence of declines in general intellectual abilities (i.e., IQ). Group-level data indicate subtle declines over time on average, but no study has utilized a clinical criterion to identify and describe a reliabl
Autor:
David R. Grosshans, Laura Janzen, Donald J. Mabbott, Vijay Ramaswamy, Lisa S. Kahalley, William E. Whitehead, Derek S. Tsang, Anita Mahajan, Murali Chintagumpala, M. Douglas Ris, Michael D. Taylor, David Hodgson, Robert C. Dauser, Rachel K. Peterson, Eric Bouffet, Normand Laperriere, Arnold C. Paulino, M. Fatih Okcu
Publikováno v:
J Clin Oncol
Autor:
E. Mark Mahone, Maria C. Rothhaar, Keith Owen Yeates, Michael E. Scheurer, Kimberly P. Raghubar, M. Douglas Ris, David R. Grosshans
Publikováno v:
Pediatric bloodcancerREFERENCES. 67(4)
BACKGROUND Research on neurodevelopmental outcome in survivors of pediatric brain tumor (BT) is often based on the assumption of normal development up to the onset of overt symptoms. We sought to verify the "normalcy assumption" and to investigate co